Rapid test for Covid-19 shows improved sensitivity
A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic.
A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic.
MIT course on the Covid-19 pandemic, available to the public online, brings together top experts to educate students on up-to-date science.
New book for the general public explains how novel viruses such as SARS-Cov-2 emerge and how we can fight them.
Over 8,000 tests were performed last week by MIT Medical.
Sequential immunization might be safer and more effective than the existing tetravalent vaccine.
Differently shaped RNA molecules allow HIV to express different genes from the same RNA sequence.
New CRISPR-based research tool delivers results in an hour; researchers share protocol and kits to advance research and move toward clinical validation.
MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.
Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
Report offers guidelines to help prevent viruses from tainting biopharmaceutical drugs.
Study finds specific cells in the lungs, nasal passages, and intestines that are more susceptible to infection.
Chemical engineer aims to create a test that can work in 10 minutes and doesn’t require specialized instruments or laboratory infrastructure.
Team designs antibody-like receptor proteins that can bind to cytokines, as possible strategy for treating coronavirus and other infections.
Materials scientist explores why some household cleaners could harm the protective coating on a smartphone screen.
MIT scientists Omar Abudayyeh and Jonathan Gootenberg explain the current state of Covid-19 testing, and how a CRISPR tool may help solve the supply problem.